{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:39:31Z","timestamp":1790854771846,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.09.058","type":"journal-article","created":{"date-parts":[[2009,9,27]],"date-time":"2009-09-27T08:09:42Z","timestamp":1254038982000},"page":"7096-7104","source":"Crossref","is-referenced-by-count":21,"title":["Development of recombinant vaccines against IL-12\/IL-23 p40 and in vivo evaluation of their effects in the downregulation of intestinal inflammation in murine colitis"],"prefix":"10.1016","volume":"27","author":[{"given":"Qingdong","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"China-Li","family":"Hillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gefei","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.09.058_bib1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.immunol.16.1.495","article-title":"The interleukin-12\/interleukin-12-receptor system: role in normal and pathologic immune responses","volume":"16","author":"Gately","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2009.09.058_bib2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.0105-2896.2004.00214.x","article-title":"IL-12 and IL-23: master regulators of innate and adaptive immunity","volume":"202","author":"Langrish","year":"2004","journal-title":"Immunol Rev"},{"issue":"7","key":"10.1016\/j.vaccine.2009.09.058_bib3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1648","article-title":"New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions","volume":"5","author":"Hunter","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.058_bib4","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.coi.2007.07.020","article-title":"Th17: the third member of the effector T cell trilogy","volume":"19","author":"Bettelli","year":"2007","journal-title":"Curr Opin Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.09.058_bib5","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/eji.200838535","article-title":"Induction, function and regulation of IL-17-producing T cells","volume":"38","author":"Mills","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2009.09.058_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev.med.58.121205.100607","article-title":"Cytokine therapy for Crohn's disease: advances in translational research","volume":"58","author":"Pizarro","year":"2007","journal-title":"Annu Rev Med"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2009.09.058_bib7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/brain\/awl273","article-title":"Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia","volume":"130","author":"Li","year":"2007","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.058_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrd1986","article-title":"Evolving knowledge and therapy of inflammatory bowel disease","volume":"5","author":"Korzenik","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.vaccine.2009.09.058_bib9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1132","article-title":"The immunological and genetic basis of inflammatory bowel disease","volume":"3","author":"Bouma","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.058_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/01.mog.0000231808.10773.8e","article-title":"New mediators of immunity and inflammation in inflammatory bowel disease","volume":"22","author":"Monteleone","year":"2006","journal-title":"Curr Opin Gastroenterol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.058_bib11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3748\/wjg.14.390","article-title":"Immunopathogenesis of inflammatory bowel disease","volume":"14","author":"Shih","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"7152","key":"10.1016\/j.vaccine.2009.09.058_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.058_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nm0107-26","article-title":"IL-23: a master regulator in Crohn disease","volume":"13","author":"Neurath","year":"2007","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.vaccine.2009.09.058_bib14","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1136\/gut.2006.115402","article-title":"The IL23 axis plays a key role in the pathogenesis of IBD","volume":"56","author":"McGovern","year":"2007","journal-title":"Gut"},{"issue":"29","key":"10.1016\/j.vaccine.2009.09.058_bib15","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.3748\/wjg.v12.i29.4628","article-title":"Novel strategies for the treatment of inflammatory bowel disease: selective inhibition of cytokines and adhesion molecules","volume":"12","author":"Nakamura","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.09.058_bib16","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1172\/JCI19836","article-title":"Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis","volume":"113","author":"Fuss","year":"2004","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.058_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI11849","article-title":"Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies","volume":"108","author":"Chackerian","year":"2001","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.058_bib18","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/eji.200636658","article-title":"Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis","volume":"36","author":"Rohn","year":"2006","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.058_bib19","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1002\/eji.200636484","article-title":"Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis","volume":"36","author":"Sonderegger","year":"2006","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.058_bib20","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1002\/eji.200636662","article-title":"Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis","volume":"36","author":"Uyttenhove","year":"2006","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.058_bib21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1164\/rccm.200610-1405OC","article-title":"Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice","volume":"176","author":"Ma","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2009.09.058_bib22","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1365-2222.2007.02741.x","article-title":"Novel IgE peptide-based vaccine prevents the increase of IgE and down-regulates elevated IgE in rodents","volume":"37","author":"Peng","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.vaccine.2009.09.058_bib23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1398-9995.2007.01384.x","article-title":"Novel cytokine peptide-based vaccines: an interleukin-4 vaccine suppresses airway allergic responses in mice","volume":"62","author":"Ma","year":"2007","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.058_bib24","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1016\/j.jaci.2006.11.650","article-title":"Tumour necrosis factor alpha (TNF) peptide-based vaccines suppress murine airway allergic responses","volume":"119","author":"Ma","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2009.09.058_bib25","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.1016\/j.vaccine.2007.09.009","article-title":"A potential immunotherapy approach: mucosal immunization with an IL-13 peptide-based and virus-like particle vaccine in a mouse asthma model","volume":"25","author":"Ma","year":"2007","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2009.09.058_bib26","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1093\/emboj\/19.14.3530","article-title":"Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12","volume":"19","author":"Yoon","year":"2000","journal-title":"Embo J"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.058_bib27","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jmb.2008.08.001","article-title":"Crystal structures of the pro-inflammatory cytokine interleukin-23 and its complex with a high-affinity neutralizing antibody","volume":"382","author":"Beyer","year":"2008","journal-title":"J Mol Biol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.058_bib28","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jmb.2008.07.051","article-title":"The structure of interleukin-23 reveals the molecular basis of p40 subunit sharing with interleukin-12","volume":"382","author":"Lupardus","year":"2008","journal-title":"J Mol Biol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.058_bib29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00262-006-0238-3","article-title":"The distinct effects of three tandem repeats of C3d in the immune responses against tumor-associated antigen hCGbeta by DNA immunization","volume":"56","author":"Guan","year":"2007","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"10.1016\/j.vaccine.2009.09.058_bib30","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.4049\/jimmunol.178.9.5859","article-title":"Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis","volume":"178","author":"Fichtner-Feigl","year":"2007","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.058_bib31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2249.2007.03350.x","article-title":"In vivo treatment with the herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium-induced colitis","volume":"148","author":"Hausmann","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.09.058_bib32","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/01.mib.0000227817.54969.5e","article-title":"Critical appraisal of the current practice in murine TNBS-induced colitis","volume":"12","author":"Te Velde","year":"2006","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.058_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.vascn.2003.12.002","article-title":"Animal models of inflammatory bowel disease","volume":"50","author":"Jurjus","year":"2004","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.058_bib34","first-page":"207","article-title":"Mouse models of inflammatory bowel disease","volume":"9","author":"Byrne","year":"2006","journal-title":"Curr Opin Drug Discov Devel"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.058_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cyto.2007.09.014","article-title":"IL-17\/Th17 targeting: on the road to prevent chronic destructive arthritis?","volume":"41","author":"Lubberts","year":"2008","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.058_bib36","first-page":"163","article-title":"Immunogenicity of infliximab: how to handle the problem?","volume":"70","author":"Baert","year":"2007","journal-title":"Acta Gastroenterol Belg"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.058_bib37","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jaci.2007.09.022","article-title":"Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma","volume":"120","author":"Limb","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.058_bib38","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jaci.2007.06.038","article-title":"Severe serum sickness-like syndrome after omalizumab therapy for asthma","volume":"120","author":"Pilette","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.058_bib39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1359-6101(03)00004-2","article-title":"Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases","volume":"14","author":"Zagury","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.058_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1359-6446(03)02955-6","article-title":"Anti-cytokine Ab immune therapy: present status and perspectives","volume":"9","author":"Zagury","year":"2004","journal-title":"Drug Discov Today"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.058_bib41","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000076441","article-title":"Induction of TNF-alpha autoantibody production by AutoVac TNF106: a novel therapeutic approach for the treatment of allergic diseases","volume":"133","author":"Zuany-Amorim","year":"2004","journal-title":"Int Arch Allergy Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.09.058_bib42","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1073\/pnas.0611022104","article-title":"VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases","volume":"104","author":"Rad","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2009.09.058_bib43","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/S0264-410X(02)00266-9","article-title":"A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses","volume":"20","author":"Jegerlehner","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.058_bib44","doi-asserted-by":"crossref","DOI":"10.1515\/BC.2008.064","article-title":"The coming of age of virus-like particle vaccines","author":"Jennings","year":"2008","journal-title":"Biol Chem"},{"issue":"26","key":"10.1016\/j.vaccine.2009.09.058_bib45","doi-asserted-by":"crossref","first-page":"14648","DOI":"10.1073\/pnas.94.26.14648","article-title":"Role of B cells in antigen presentation of the hepatitis B core","volume":"94","author":"Milich","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.058_bib46","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.4049\/jimmunol.169.11.6120","article-title":"Determinants of autoantibody induction by conjugated papillomavirus virus-like particles","volume":"169","author":"Chackerian","year":"2002","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.058_bib47","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1128\/IAI.72.11.6519-6527.2004","article-title":"Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes","volume":"72","author":"Nardin","year":"2004","journal-title":"Infect Immun"},{"issue":"26","key":"10.1016\/j.vaccine.2009.09.058_bib48","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1056\/NEJM199912233412603","article-title":"Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group","volume":"341","author":"Milgrom","year":"1999","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.058_bib49","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1002\/eji.200737766","article-title":"IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells","volume":"37","author":"Fantini","year":"2007","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.058_bib50","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4049\/jimmunol.167.2.749","article-title":"IL-12 decreases activation-induced cell death in human naive Th cells costimulated by intercellular adhesion molecule-1. I. IL-12 alters caspase processing and inhibits enzyme function","volume":"167","author":"Palmer","year":"2001","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2009.09.058_bib51","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.4049\/jimmunol.169.7.3637","article-title":"IL-12 provides proliferation and survival signals to murine CD4+ T cells through phosphatidylinositol 3-kinase\/Akt signaling pathway","volume":"169","author":"Yoo","year":"2002","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,16]],"date-time":"2018-12-16T09:50:53Z","timestamp":1544953853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09013929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":51,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0264410X09013929"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}